CHANGE: A randomized controlled trial of a psychological intervention for alcohol misuse and mental health comorbidities in conflict-affected populations in Ukraine

ISRCTN ISRCTN14881856
DOI https://doi.org/10.1186/ISRCTN14881856
Secondary identifying numbers 28853, 219468/Z/19/Z
Submission date
20/06/2024
Registration date
05/07/2024
Last edited
12/08/2025
Recruitment status
Recruiting
Overall study status
Ongoing
Condition category
Mental and Behavioural Disorders
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English summary of protocol

Background and study aims
We are currently experiencing the highest levels of forced displacement ever recorded. People affected by conflict are particularly vulnerable to mental health issues and are at a significantly higher risk of developing mental disorders, including problems with alcohol, compared to those not affected by conflict.

To help these populations, the World Health Organization (WHO) has created a program called Problem Management Plus (PM+). This program involves a short series of five sessions, delivered by trained non-specialists, designed to address common mental health issues in communities facing hardship.

The proposal in question is part of a larger, five-year initiative known as the CHANGE project. This project aims to expand on the PM+ program by developing a brief, adaptable intervention that targets both psychological distress and alcohol misuse.

The main goal is to evaluate how effective and cost-effective the CHANGE intervention is. The primary hypothesis is that the CHANGE intervention, when combined with enhanced usual care (EUC), will be more effective than EUC alone in increasing the number of days people abstain from alcohol over a three-month period. Additionally, it is hypothesized that the CHANGE intervention combined with EUC will be more cost-effective and save more money for the healthcare system compared to EUC alone.

This current protocol is based on two previous protocols and utilizes a finalized treatment manual developed after a pilot randomized controlled trial (RCT) (approved by the LSHTM Research Ethics Committee ID: 28853 and its amendment 28853-2). The focus of the current protocol is solely on the full-scale RCT.

Who can participate?
Adult war-affected Ukrainian males (18 years and older) residing in Ukraine, with alcohol use disorder (AUDIT score 8-19) and self-reported elevated levels of psychological distress (K10>16).

What does the study involve?
To determine how effective and cost-effective the CHANGE intervention is, a specific type of study will be conducted in Ukraine. This study is called a parallel arm, single-blind, definitive, individual randomized controlled trial (RCT). It will involve 500 participants who will be randomly assigned to one of two groups: one group will receive the CHANGE intervention along with enhanced usual care (EUC), and the other group will receive only EUC.

The cost-effectiveness of the CHANGE intervention will be measured by calculating the additional cost per disability-adjusted life year (DALY) averted and the cost per quality-adjusted life year (QALY) gained compared to EUC alone. These measures will be considered from a societal perspective over the participants' lifetimes.

Participants in the treatment group will go through five or six sessions in remote format (online or via telephone) of the CHANGE intervention along with EUC. The EUC component will include an information pamphlet that provides advice on reducing alcohol consumption and managing psychological distress. The CHANGE intervention is a low-intensity psychological program, delivered by trained facilitators under the supervision of mental health professionals. The control group will receive only the EUC.

The main outcome of the study will be the increase in the percentage of days participants abstain from alcohol, measured three months after the intervention using a method called the timeline follow back assessment.

What are the possible benefits and risks of participating?
Potential benefits of Participation:
Participants will:
1. Receive our personalized intervention which aims to lower alcohol intake and improve mental well-being.
2. Leaflet with information about impact of alcohol misuse on body and mind to support your healthier lifestyle.
3. Advance research that could benefit many worldwide, starting with Ukraine.
4. Receive compensation, including 250 UAH for assessments and interviews, but not for session attendance.

Potential risks of Participation
Participants might find discussing some details of mental health and alcohol consumption with someone who you do not know uncomfortable or upsetting. If participant become upset, he will be able to speak with an appropriate member of NaUKMA Mental Health Center and provided with information about available mental health resources that can help.

Where is the study run from?
The London School of Hygiene & Tropical Medicine (UK)

When is the study starting and how long is it expected to run for?
April 2024 to January 2026

Who is funding the study?
NIHR–Wellcome Partnership for Global Health Research (UK)

Who is the main contact?
Study PI, Prof. Bayard Roberts, Bayard.Roberts@lshtm.ac.uk
Local Site PI, Dr. Sergiy Bogdanov, s.bogdanov@ukma.edu.ua

Study website

Contact information

Dr Sergiy Bogdanov
Scientific

Godzenka Dmytra 2/4
Kyiv
01042
Ukraine

ORCiD logoORCID ID 0000-0001-8811-3453
Phone +38 (0)660304020
Email s.bogdanov@ukma.edu.ua
Prof Bayard Roberts
Principal Investigator

London School of Hygiene & Tropical Medicine
15-17 Tavistock Place
London
WC1H 9SH
United Kingdom

ORCiD logoORCID ID 0000-0003-4482-5859
Phone +44 (0)20 7636 8636
Email Bayard.Roberts@lshtm.ac.uk
Ms Viktoria Kachay
Public

Godzenka Dmytra 2/4
Kyiv
01042
Ukraine

Phone +38(093)8171801
Email v.kachay@ukma.edu.ua

Study information

Study designParallel arm single-blind randomized controlled trial with a nested qualitative study
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Community, Internet/virtual, Telephone
Study typeTreatment
Participant information sheet 45666 PIS 2.6 Facilitator qualitative interview.pdf
Scientific titleA Randomized Controlled Trial (RCT) of a psychological intervention for alcohol misuse and mental health comorbidities in conflict-affected populations in Ukraine
Study acronymCHANGE
Study objectives1. The new psychological intervention CHANGE and enhanced usual care reduced amount of alcohol consumption and symptoms of psychological stress better then enhanced usual care only
2. The new psychological intervention CHANGE and enhanced usual care is more cost-effective then enhanced usual care only
Ethics approval(s)

1. Approved 17/04/2024, LSHTM Research Ethics Committee (15-17 Tavistock Place, London, WC1H 9SH, United Kingdom; +44(0)2076368636; ethics@lshtm.ac.uk), ref: 30122 - 01

2. Approved 03/06/2024, NaUKMA Commettee on Research Ethics (Skovorody str, 2, Kyiv, 04070, Ukraine; +38 (0)44 425 60 64; t.yurochko@ukma.edu.ua), ref: ref: #4 from 03/06/2024

Health condition(s) or problem(s) studiedAlcohol misuse and psychological stress
InterventionThis research entails a parallel arm, single-blind, definitive, individually randomized controlled trial (RCT) in Ukraine government-controlled territories in a remote format. This RCT will include 500 study participants, randomised 1:1 to treatment (CHANGE) and control arm, and outcome assessment will be collected at baseline, 3 months post-recruitment.

The CHANGE intervention is based on PM+. PM+ is a brief, psychological intervention based on cognitive behavioural therapy (CBT) techniques that are empirically supported and formally recommended by the WHO (Dua, Barbui, Clark, Fleischmann, Poznyak, Ommeren, et al., 2011; W. a Tol et al., 2013; WHO, 2013). PM+ was developed by the WHO and the University of New South Wales, Australia. The manual involves the following empirically supported elements: problem-solving plus stress management, behavioural activation, facing fears, and accessing social support. These elements have been recommended in recent WHO guidelines (Dua, Barbui, Clark, Fleischmann, Poznyak, van Ommeren, et al., 2011; Tol et al., 2013). The CHANGE intervention is based on PM+ strategies to treat underlying symptoms of common mental disorders and has an additional psychological component that addresses alcohol misuse. The CHANGE intervention is composed of three phases each of which includes two individual face-to-face sessions (approximately 90 minutes each).

Furthermore, to assess the cost-effectiveness of the intervention, we will assess the incremental cost per DALY averted and cost per QALY of the CHANGE intervention compared to EUC from a societal perspective over a lifetime horizon.

Lastly, a nested qualitative study will be carried out wherein qualitative interviews will be conducted with participants, facilitators, research assistants and family members of those who took part in the CHANGE intervention to investigate implementation processes, intervention delivery, fidelity, dose, sustainability, perceived effectiveness, feasibility, and acceptability. Thematic analysis will be used using an inductive approach to analysis.
Intervention typeBehavioural
Primary outcome measurePDHD (percentage days of heavy drinking) measured using a Timeline Followback (TLFB)  at baseline and 3 months
Secondary outcome measures1. PDA (percentage of days abstinent) measured using a Timeline Followback (TLFB) at baseline and 3 months
2. Alcohol misuse  measured using the Alcohol Use Disorders Identification Test (AUDIT) at baseline and 3 months
3. Alcohol misuse  measured using the Alcohol, Smoking and Substance Involvement Screening Test (ASSIST)  at baseline and 3 months
4. Psychological distress measured using a Kessler-10 (K-10) at baseline and 3 months
5. Depression measured using a Mental Health Assessment Inventory (MHAI), Depression sub-scale at baseline and 3 months
6. Anxiety measured using a Mental Health Assessment Inventory (MHAI), anxiety sub-scale at baseline and 3 months
7. PTSD measured using a Mental Health Assessment Inventory (MHAI), PTSD sub-scale at baseline and 3 months
8. Functional disability measured using a Mental Health Assessment Inventory (MHAI), WHODAS sub-scale at baseline and 3 months
9. Perpetration of intimate partner violence measured using a United Nations Multi-Country Study on Men and Violence  at baseline and 3 months
10. Health economics indicators measured using a EQ-5D-5L, Subjective wellbeing (happiness and life satisfaction) and OxCAP-MH at baseline and 3 months
Overall study start date30/04/2024
Completion date30/01/2026

Eligibility

Participant type(s)Population
Age groupAdult
Lower age limit18 Years
SexMale
Target number of participants500
Key inclusion criteria1. Adult men (>18 years)
2. Alcohol Use Disorder Identification Test (AUDIT) score 8-19 (Saunders, Aasland, Babor, de la Fuente, et al., 1993)
3. Elevated levels of psychological distress (Kessler Psychological Distress Scale (ten item version) (K10>16) (Kessler et al., 2010).
4. Speak Ukrainian or Russian
Key exclusion criteria1. Men with possible alcohol dependence (AUDIT score ≥20).
2. Imminent risk of suicide/other life-threatening risk, acute medical conditions assessed through three questions related to suicide (i.e., ‘in the last month have you had thoughts about suicide? (harming another person)/ or a suicide plan? (a plan to harm another person). Do you have ways to carry out this plan?/Have you tried to kill yourself in the past month? (to kill or harm another person). These participants will be referred to a psychiatrist.
3. Signs of severe mental disorders such as psychosis and/or severed cognitive impairment (e.g. severe intellectual disability or dementia). This will be assessed using a checklist with lists of observable signs of severe mental disorders or severe cognitive impairment such as participant not understanding questions, presenting with confused speech, appearing extremely fidgety or nervous, limited communication skills, etc.).
4. Has received formalized brief psychological interventions (e.g., PM+, CETA) in the previous year
5. Has received any forms of any substance use treatment (e.g., AA, detoxication, replacement therapy programs) in their lifetime
6. Men who are actively involved in military action
7. Residence outside of Ukraine
Date of first enrolment25/06/2024
Date of final enrolment10/09/2025

Locations

Countries of recruitment

  • Ukraine

Study participating centre

National University of "Kyiv-Mohyla Academy"
Skovorody Street, 2
Kyiv
04070
Ukraine

Sponsor information

London School of Hygiene & Tropical Medicine
University/education

Keppel St
London
WC1E 7HT
England
United Kingdom

Phone +44 20 7636 8636
Email bayard.roberts@lshtm.ac.uk
Website http://www.lshtm.ac.uk/
ROR logo "ROR" https://ror.org/00a0jsq62

Funders

Funder type

Government

NIHR–Wellcome Partnership for Global Health Research

No information available

Results and Publications

Intention to publish date30/06/2026
Individual participant data (IPD) Intention to shareYes
IPD sharing plan summaryAvailable on request
Publication and dissemination planPlanned publications in a peer-reviewed journals
IPD sharing planThe datasets generated during and/or analysed during the current study will be available upon request from Dr. Sergiy Bogdanov s.bogdanov@ukma.edu.ua

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Participant information sheet Facilitator qualitative interview 01/07/2024 No Yes
Participant information sheet Non-participant qualitative interview 01/07/2024 No Yes
Participant information sheet Participant dropout qualitative interview 01/07/2024 No Yes
Participant information sheet Participant family members qualitative interview 01/07/2024 No Yes
Participant information sheet Participants qualitative interviews 01/07/2024 No Yes
Participant information sheet Participants quantitative data collection 01/07/2024 No Yes
Participant information sheet Research assistant qualitative interview 01/07/2024 No Yes
Participant information sheet Supervisor qualitative interview 01/07/2024 No Yes
Statistical Analysis Plan 12/08/2025 No No

Additional files

45666 PIS 2.1 Participants quantitative data collection.pdf
Participants quantitative data collection
45666 PIS 2.2 Participants qualitative interviews.pdf
Participants qualitative interviews
45666 PIS 2.3 Participant family members qualitative interview.pdf
Participant family members qualitative interview
45666 PIS 2.4 Non-participant qualitative interview.pdf
Non-participant qualitative interview
45666 PIS 2.5 Supervisor qualitative interview.pdf
Supervisor qualitative interview
45666 PIS 2.6 Facilitator qualitative interview.pdf
Facilitator qualitative interview
45666 PIS 2.7 Research assistant qualitative interview.pdf
Research assistant qualitative interview
45666 PIS 2.8 Participant dropout qualitative interview.pdf
Participant dropout qualitative interview
ISRCTN14881856_SAP.pdf

Editorial Notes

12/08/2025: Statistical analysis plan uploaded.
12/03/2025: The plain English summary was updated.
19/08/2024: The sponsor was changed from NIHR–Wellcome Partnership for Global Health Research to LSHTM.
01/07/2024: Trial's existence confirmed by LSHTM Research Ethics Committee.